标普和纳斯达克内在价值 联系我们

Polydex Pharmaceuticals Limited POLXF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
15/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Polydex Pharmaceuticals Limited (POLXF) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 14/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
15/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
0/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — POLXF

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2001 $0.04 $13.65M $131.28K 1%
2002 $-0.07 $12.17M $-206.88K -1.7%
2003 $-0.22 $12.79M $-673.74K -5.3%
2004 $0.00 $14.09M $-6K -0%
2005 $0.37 $6.37M $1.14M 17.9%
2006 $-0.49 $5.27M $-1.49M -28.3%
2007 $-0.09 $6.5M $-260.62K -4%
2008 $-0.29 $5.73M $-885.21K -15.4%
2009 $-0.52 $4.82M $-1.59M -33%
2010 $0.00 $4.48M $-2.2M -49.1%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言